id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3004746,bbaeab87-e489-4662-a84e-e01bd8cdc7c7,Q2,TIBER CREEK GROUP,20744,"BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)",2023,second_quarter,HCR,"Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA, Consolidated Appropriations Act, 2023 (PL 117-328).","HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2023-07-14T18:26:26-04:00
3004747,bbaeab87-e489-4662-a84e-e01bd8cdc7c7,Q2,TIBER CREEK GROUP,20744,"BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)",2023,second_quarter,MMM,"Issues related to drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing).","HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2023-07-14T18:26:26-04:00
3004748,bbaeab87-e489-4662-a84e-e01bd8cdc7c7,Q2,TIBER CREEK GROUP,20744,"BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)",2023,second_quarter,MAN,Issues relating to US and international manufacturing.,"Commerce, Dept of (DOC),Treasury, Dept of",70000,,0,0,2023-07-14T18:26:26-04:00